The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival

Anticancer Research

Volumn 26, Issue 4 A, 2006, Pages 2605-2614

  Grant, William B ^a  

^a Sunlight   (United States)

Author keywords

Alcohol; Animal products; Insulin like growth factor I (IGF I); Sugar; Vegetables

Indexed keywords

VITAMIN D;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; COLON CANCER; CORRELATION ANALYSIS; DATA ANALYSIS; DIET; ECOLOGY; EUROPE; FEMALE; HUMAN; KIDNEY CANCER; LATITUDE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SOLAR RADIATION; STOMACH CANCER; ULTRAVIOLET B RADIATION;

DEVELOPED COUNTRIES; DIET; ECOLOGY; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; ULTRAVIOLET RAYS; VITAMIN D;

EID: 33644813775     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (106)

1. Doll R and Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66: 1191-1308, 1981.
2. World Cancer Research Fund in association with the American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: a global perspective. Wash., DC, pp. 670, 1997
3. Grant WB: An estimate of premature cancer mortality in the United States due to inadequate doses of solar ultraviolet-B radiation. Cancer 94: 1867-1875, 2002.
4. Freedman DM, Dosemeci M and McGlynn K: Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 57: 257-262, 2002.
5. Grant WB and Garland CF: A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 48: 115-123, 2004.
6. 3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 15: 149-158, 2004.
7. Moan J, Porojnicu AC, Robsahm TE et al: Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B 78: 189-193, 2005.
8. Porojnicu AC, Robsahm TE, Ree AH and Moan J: Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. Br J Cancer 93: 571-574, 2005.
9. Giovannucci E: The role of vitamin D in cancer incidence and prevention. Am Assoc Cancer Res Annual Meeting, 2005.
10. Zhou W, Suk R, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Giovannucci E and Christiani DC: Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 14: 2303-2309, 2005.
11. Grant WB: Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc 98: 357-364, 2006.
12. Morgenstern H: Ecologic studies. In: Modern Epidemiology, 2nd Edition (Rothman KJ, Greenland S, eds.). Lippincott, Philadelphia, pp. 459-480, 1998.
13. Greenland S: Ecologic versus individual-level sources of confounding in ecologic estimates of contextual health effects. Int J Epidemiol 30: 1343-1350, 2001.
14. Hill AB: The environment and disease: association or causation? Proc R Soc Med 58: 295-300, 1965.
15. Weed DL: Environmental epidemiology: basics and proof of cause-effect. Toxicology 181-182: 399-403, 2002.
16. Garland CF and Garland FC: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227-231, 1980.
17. Garland C, Shekelle RB, Barrett-Connor E et al: Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1: 307-309, 1985.
18. Gorham ED, Garland CF and Garland FC: Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can J Public Health 80: 96-100, 1989.
19. Gorham ED, Garland FC and Garland CF: Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19: 820-824, 1990.
20. Garland CF, Comstock GW and Garland FC et al: Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2: 1176-1178, 1989.
21. Garland FC, Garland CF, Gorham ED and Young JF: Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-622, 1990.
22. Lefkowitz ES and Garland CF: Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 23: 1133-1136, 1994.
23. Hanchette CL and Schwartz GG: Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70: 2861-2869, 1992.
24. Devesa SS, Grauman DJ, Blot WJ et al: Atlas of Cancer Mortality in the United States, 1950-1994. NIH Publication No. 99-4564, 1999. http://cancer.gov/atlasplus/new.html (accessed Sept. 21, 2005).
25. Grant WB: Benefits of UVB exposure to reduce the risk of cancer - ecologic studies of cancer mortality rates. Proceedings of the CIE Symposium '04; Light and Health: Non-visual Effects, 30 Sep.-2 Oct. 2004, Commission International de L'Eclairage, pp. 174-177, 2004.
26. Grant WB: Ecologic studies of solar UV-B radiation and cancer mortality rates. Rec Results Cancer Res 164: 371-377, 2003.
27. Grant WB and Garland CF: Association of solar ultraviolet B with reduced mortality rates of some types of cancer: multifactorial ecologic study. Poster presentation at the annual meeting of the American Association for Cancer Research, Anaheim, April 18, 2005 (available at www.sunarc.org)
28. Leffell DJ and Brash DE: Sunlight and skin cancer. Sci Am 275: 52-53, 56-59, 1996. http://toms.gsfc.nasa.gov/ery_uv/dna_exp.gif (accessed Sept. 21, 2005).
29. Nutrition Monitoring Div., Human Nutrition Information Service, U.S. Dept. of Agriculture, Food and Nutrient Intakes: Individuals in Four Regions, Year 1977-78, Hyattsville, MD, Report No. 1-3, 1985.
30. Grant WB: Geographic variation of prostate cancer mortality rates in the United States: implications for prostate cancer risk related to vitamin D. Int J Cancer 111: 470-471, 2004.
31. Tuohimaa P, Tenkanen L, Ahonen M et al: Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108: 104-108, 2004.
32. Ferlay J, Bray F, Pisani P and Parkin DM: GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0, IARCPress, Lyon, 2004. http://www-dep.iarc.fr/ (accessed Sept. 22, 2005).
33. Sant M, Aareleid T, Berrino F et al: EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 14: v61-v118, 2003.
34. Capocaccia R, Gatta G, Roazzi P et al: The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 14: v14-v27, 2003.
35. Jablonski NG and Chaplin G: The evolution of human skin coloration. J Hum Evol 39: 57-106, 2000.
36. FAOSTAT data, 2005. Last update 27 August 2004 http://faostat.fao.org/ faostat/ (accessed Sept. 22, 2005).
37. Tsuji K, Harashima E, Nakagawa Y et al: Time-lag effect of dietary fiber and fat intake ratio on Japanese colon cancer mortality. Biomed Environ Sci 9: 223-228, 1996.
38. Grant WB: An ecologic study of dietary and solar UV-B links to breast carcinoma mortality rates. Cancer 94: 272-281, 2002.
39. Huncharek M and Kupelnick B: Dietary fat intake and risk of epithelial ovarian cancer: a meta-analysis of 6,689 subjects from 8 observational studies. Nutr Cancer 40: 87-91, 2001.
40. Zheng T, Holford TR, Leaderer B et al: Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 759: 454-466, 2004.
41. Rashidkhani B, Akesson A, Lindblad P and Wolk A: Major dietary patterns and risk of renal cell carcinoma in a prospective cohort of Swedish women. J Nutr 135: 1757-1762, 2005.
42. Jacobs DR Jr, Marquart L, Slavin J and Kushi LH: Whole-grain intake and cancer: an expanded review and meta-analysis. Nutr Cancer 30: 85-96, 1998.
43. Riboli E and Norat T: Cancer prevention and diet: opportunities in Europe. Public Health Nutr 4: 475-484, 2001.
44. Shannon J, Cook LS and Stanford JL: Dietary intake and risk of postmenopausal breast cancer (United States). Cancer Causes Control 14: 19-27, 2003.
45. Fritschi L, Ambrosini GL, Kliewer EV et al: Dietary fish intake and risk of leukaemia, multiple myeloma, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13: 532-537, 2004.
46. Giovannucci E: Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 55: 694-704, 2003.
47. Kaaks R: Endogenous hormone metabolism as an exposure marker in breast cancer chemoprevention studies. IARC Sci Publ 154: 149-162, 2001.
48. Yu H, Shu XO, Li BD et al: Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. Cancer Epidemiol Biomarkers Prev 12: 1067-1073, 2003.
49. Mandelson MT, Miglioretti D, Newcomb PA et al: Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. Cancer Causes Control 14: 979-984, 2003.
50. Bruce WR, Giacca A and Medline A: Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9: 1271-1279, 2000.
51. van der Wielen RP, Lowik MR, van den Berg H et al: Serum vitamin D concentrations among elderly people in Europe. Lancet 346: 207-210, 1995.
52. SPSS 13.0 Brief Guide, SPSS Inc., Chicago, 2004.
53. Ikuyama T, Hamasaki T, Inatomi H et al: Association of vitamin D receptor gene polymorphism with renal cell carcinoma in Japanese. Endocr J 49: 433-438, 2002.
54. Holick MF: Vitamin D for health and in chronic kidney disease. Semin Dial 18: 266-275, 2005.
55. Cho E, Spiegelman D, Hunter DJ et al: Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst 95: 1079-1085, 2003.
56. Launoy G, Milan C, Day NE et al: Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int J Cancer 76: 7-12, 1998.
57. Onuk MD, Oztopuz A and Memik F: Risk factors for esophageal cancer in eastern Anatolia. Hepatogastroenterology 49: 1290-1292, 2002.
58. De Stefani E, Boffetta P, Deneo-Pellegrini H et al: The role of vegetable and fruit consumption in the aetiology of squamous cell carcinoma of the oesophagus: a case-control study in Uruguay. Int J Cancer 116: 130-135, 2005.
59. Shafey O, Dolwick S and Guindon GE (eds.): Tobacco Control Country Profiles, Second Edition, 2003. American Cancer Society, World Health Organization, and International Union Against Cancer. http://www.wpro.who.int/ NR/rdonlyres/437C3114-24FE-45CA-9A62-8E119BC66CC6/0/TCCP2.pdf (accessed September 8, 2005).
60. Hu S, Ma F, Collado-Mesa F and Kirsner RS: Ultraviolet radiation and incidence of non-Hodgkin's lymphoma among Hispanics in the United States. Cancer Epidemiol Biomarkers Prev 13: 59-64, 2004.
61. Hughes AM, Armstrong BK, Vajdic CM et al: Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 112: 865-871, 2004.
62. Smedby KE, Hjalgrim H, Melbye M et al: Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97: 199-209, 2005.
63. Adami J, Gridley G, Nyren O et al: Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 80: 641-645, 1999.
64. Hakansson N, Floderus B, Gustavsson P et al: Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 12: 552-557, 2001.
65. Hu S, Federman DG, Ma F and Kirsner RS: Skin cancer and non-Hodgkin's lymphoma: examining the link. Dermatol Surg 31: 76-82, 2005.
66. Moan J, Dahlback A and Setlow RB: Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem Photobiol 70: 243-247, 1999.
67. Green A, Williams G, Neale R et al: Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354: 723-729, 1999.
68. Fisher SG and Fisher RI: The epidemiology of non-Hodgkin's lymphoma. Oncogene 23: 6524-6534, 2004.
69. Brennan P, Scelo G, Hemminki K et al: Second primary cancers among 109,000 cases of non-Hodgkin's lymphoma. Br J Cancer 93: 159-166, 2005.
70. Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 571: 185-205, 2005.
71. Garland CF, Garland FC and Gorham ED: Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates. Ann Epidemiol 13: 395-404, 2003.
72. Grant WB: Dietary fiber and colorectal cancer. Townsend Lett 192: 112-113, 1999.
73. Cross HS, Peterlik M, Reddy GS and Schuster I: Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol 62: 21-28, 1997.
74. Zehnder D, Bland R, Williams MC et al: Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001.
75. Cross HS, Bareis P, Hofer H et al: 25-Hydroxyvitamin D(3)-1alpha- hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66: 287-292, 2001.
76. Bareis P, Bises G, Bischof MG et al: 25-Hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 285: 1012-1017, 2001.
77. Bises G, Kallay E, Weiland T et al: 25-Hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52: 985-989, 2004.
78. Kallay E, Bises G, Bajna E et al: Colon-specific regulation of vitamin D hydroxylases - a possible approach for tumor prevention. Carcinogenesis 26: 1581-1589, 2005.
79. Peterlik M and Cross HS: Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 35: 290-304, 2005.
80. van den Bemd GJ and Chang GT: Vitamin D and vitamin D analogs in cancer treatment. Curr Drug Targets 3: 85-94, 2002.
81. Krishnan AV, Peehl DM and Feldman D: The role of vitamin D in prostate cancer. Rec Results Cancer Res 164: 205-221, 2003.
82. Lucotte G, Loirat F and Hazout S: Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. Hum Biol 69: 253-262, 1997.
83. Vijan S, Hwang EW, Hofer TP and Hayward RA: Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 111: 593-601, 2001.
84. Gotzsche PC and Olsen O: Is screening for breast cancer with mammography justifiable? Lancet 355: 129-134, 2000.
85. Green BB and Taplin SH: Breast cancer screening controversies. J Am Board Fam Pract 16: 233-241, 2003.
86. Gibbons L and Waters C: Prostate cancer - testing, incidence, surgery and mortality. Health Rep 14: 9-20, 2003.
87. Jemal A, Ward E, Wu X et al: Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidemiol Biomarkers Prev 14: 590-595, 2005.
88. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69: 842-856, 1999.
89. Banerjee P and Chatterjee M: Antiproliferative role of vitamin D and its analogs - a brief overview. Mol Cell Biochem 253: 247-254, 2003.
90. Beer TM and Myrthue A: Calcitriol in cancer treatment: from the lab to the clinic. Mol Cancer Ther 3: 373-381, 2004.
91. Rasmussen LB, Hansen GL, Hansen E et al: Vitamin D: should the supply in the Danish population be increased? Int J Food Sci Nutr 51: 209-215, 2000.
92. Ovesen L, Andersen R and Jakobsen J: Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 62: 813-821, 2003.
93. Newmark HL, Heaney RP and Lachance PA: Should calcium and vitamin D be added to the current enrichment program for cereal-grain products? Am J Clin Nutr 80: 264-270, 2004.
94. Mocanu V, Stitt PA, Costin AR et al: Long-term efficacy and safety of high vitamin D intakes as fortified bread. Experimental Biology 2005 meeting. April 2. San Diego. Abstract available at http://www.eb2005-online.com/pdfs/ 009665.PDF?PHPSESSID=1c3b0454d98b47ca5a0cbd6c57920.
95. Malabanan AO and Holick MF: Vitamin D and bone health in postmenopausal women. J Womens Health (Larchmt) 12: 151-156, 2003.
96. Plotnikoff GA and Quigley JM: Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78: 1463-1470, 2003.
97. Cantorna MT and Mahon BD: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229: 1136-1142, 2004.
98. Li YC, Qiao G, Uskokovic M et al: Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90: 387-392, 2004.
99. Heaney RP: Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr 78: 912-919, 2003.
100. Holick MF: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371, 2004.
101. Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80: 1678S-1688S, 2004.
102. Mosekilde L: Vitamin D and the elderly. Clin Endocrinol (Oxf) 62: 265-281, 2005.
103. Ponsonby AL, Lucas RM and van der Mei IA: UVR, vitamin D and three autoimmune diseases - multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol 81: 1267-1275, 2005.
104. Grant WB and Holick MF: Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10: 94-111, 2005.
105. Grant WB, Garland CF and Holick MF: Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol 81: 1276-1286, 2005.
106. Staud R: Vitamin D: more than just affecting calcium and bone. Curr Rheumatol Rep 7: 356-364, 2005.